Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine versus remimazolam sedation during spinal anesthesia for lower extremity surgery
KCT0007138Phase 4Recruiting
- Sponsor
- Hana Pharm
- Start
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial comparing Dexmedetomidine sedation with Remimazolam sedation (2 arms). Primary endpoint: Frequency of hypotensive episodes. Started Jul 2022; status: recruiting.
02
Drugs
dexmedetomidineremimazolam
Beyond the preview
Go deeper on KCT0007138.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0007138.